tiprankstipranks
Trending News
More News >
Mindbio Therapeutics Corp. (TSE:MBIO)
:MBIO
Canadian Market

Mindbio Therapeutics Corp. (MBIO) Income Statement

Compare
12 Followers

Mindbio Therapeutics Corp. Income Statement

Last quarter (Q4 2024), Mindbio Therapeutics Corp.'s total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Mindbio Therapeutics Corp.'s net income was $-45.82K. See Mindbio Therapeutics Corp.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23
Total Revenue
$ ―$ ―
Gross Profit
$ ―$ ―
Operating Expenses
$ ―$ ―
Depreciation and Amortization
$ ―$ ―
EBITDA
$ -56.64K$ -4.25M
Operating Income
$ -55.95K$ ―
Other Income/Expenses
$ ―$ ―
Pretax Income
$ ―$ ―
Net Income
$ -415.64K$ ―
Per Share Metrics
Basic EPS
$ ―$ ―
Diluted EPS
$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Mindbio Therapeutics Corp. Earnings and Revenue History